ID

13776

Descrição

A Study of Tarceva (Erlotinib) in Patients With Locally Advanced, Metastatic or Recurrent Non-Small Cell Cancer Who Present Epidermal Growth Factor Receptor Mutations; ODM derived from: https://clinicaltrials.gov/show/NCT01372384

Link

https://clinicaltrials.gov/show/NCT01372384

Palavras-chave

Versões (1)
  1. 06/03/2016 06/03/2016 -
Transferido a

6 de março de 2016

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Non-Squamous Non-Small Cell Lung Cancer NCT01372384

Inglês

Eligibility Non-Squamous Non-Small Cell Lung Cancer NCT01372384

1 Formulários  
Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
adult patients, >/= 18 years of age
Descrição

age

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0001779
locally advanced (stage iiib), metastatic (stage iv) or recurrent non-small cell lung cancer with mutations in the tyrosine kinase domain of the epidermal growth factor receptor (egfr)
Descrição

non-small cell lung cancer; Tyrosine kinase mutation; epidermal growth factor receptor

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0007131
UMLS CUI [2]
C3267004
UMLS CUI [3]
C0034802
at least one measurable lesion according to recist criteria
Descrição

lesion

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0221198
european cooperative oncology group (ecog) performance status 0-2
Descrição

ecog

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1520224
adequate hematological, liver and renal function
Descrição

liver function; renal function; Hematologic function

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0232741
UMLS CUI [2]
C0232804
UMLS CUI [3]
C0221130
patients with stable cerebral metastases who have received surgical or radiotherapy will be eligible
Descrição

Cerebral metastasis; radiotherapy; surgery

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0555278
UMLS CUI [2]
C1522449
UMLS CUI [3]
C0543467
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous chemotherapy or therapy against egfr for metastatic disease (neoadjuvant or adjuvant therapy after radical surgery is allowed if finalized >/= 6 months before entering the study)
Descrição

chemotherapy; therapy egfr; Neoadjuvant Therapy; adjuvant therapy; surgery

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C0034802
UMLS CUI [3]
C0600558
UMLS CUI [4]
C0677850
UMLS CUI [5]
C0543467
history of another neoplasm except for carcinoma in situ of the cervix, adequately treated basal cell skin carcinoma, radically treated prostate carcinoma with good prognosis (gleason </= 6), or another curatively treated neoplasm without evidence of disease in the last 5 years
Descrição

cervix carcinoma in situ; basal cell skin carcinoma; prostate carcinoma; good prognosis

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0851140
UMLS CUI [2]
C0007117
UMLS CUI [3]
C0600139
UMLS CUI [4]
C0278250
symptomatic cerebral metastases
Descrição

cerebral metastasis

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0555278
any significant ophthalmologic abnormality
Descrição

Eye Abnormalities

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0015393
use of coumarins
Descrição

Coumarins

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0010207
pregnant or breast-feeding women
Descrição

pregnancy; lactating

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
pre-existing parenchymal lung disease such as pulmonary fibrosis, lymphangiosis and carcinomatosis (if this is the only presence of the disease)
Descrição

pulmonary fibrosis; Lymphangiosis carcinomatosa

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0034069
UMLS CUI [2]
C0948588
Voltar ao início da página

Similar models

Eligibility Non-Squamous Non-Small Cell Lung Cancer NCT01372384

1 Formulários
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
age
Item
adult patients, >/= 18 years of age
boolean
C0001779 (UMLS CUI [1])
non-small cell lung cancer; Tyrosine kinase mutation; epidermal growth factor receptor
Item
locally advanced (stage iiib), metastatic (stage iv) or recurrent non-small cell lung cancer with mutations in the tyrosine kinase domain of the epidermal growth factor receptor (egfr)
boolean
C0007131 (UMLS CUI [1])
C3267004 (UMLS CUI [2])
C0034802 (UMLS CUI [3])
lesion
Item
at least one measurable lesion according to recist criteria
boolean
C0221198 (UMLS CUI [1])
ecog
Item
european cooperative oncology group (ecog) performance status 0-2
boolean
C1520224 (UMLS CUI [1])
liver function; renal function; Hematologic function
Item
adequate hematological, liver and renal function
boolean
C0232741 (UMLS CUI [1])
C0232804 (UMLS CUI [2])
C0221130 (UMLS CUI [3])
Cerebral metastasis; radiotherapy; surgery
Item
patients with stable cerebral metastases who have received surgical or radiotherapy will be eligible
boolean
C0555278 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
C0543467 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
chemotherapy; therapy egfr; Neoadjuvant Therapy; adjuvant therapy; surgery
Item
previous chemotherapy or therapy against egfr for metastatic disease (neoadjuvant or adjuvant therapy after radical surgery is allowed if finalized >/= 6 months before entering the study)
boolean
C0392920 (UMLS CUI [1])
C0087111 (UMLS CUI [2,1])
C0034802 (UMLS CUI [2,2])
C0600558 (UMLS CUI [3])
C0677850 (UMLS CUI [4])
C0543467 (UMLS CUI [5])
cervix carcinoma in situ; basal cell skin carcinoma; prostate carcinoma; good prognosis
Item
history of another neoplasm except for carcinoma in situ of the cervix, adequately treated basal cell skin carcinoma, radically treated prostate carcinoma with good prognosis (gleason </= 6), or another curatively treated neoplasm without evidence of disease in the last 5 years
boolean
C0851140 (UMLS CUI [1])
C0007117 (UMLS CUI [2])
C0600139 (UMLS CUI [3])
C0278250 (UMLS CUI [4])
cerebral metastasis
Item
symptomatic cerebral metastases
boolean
C0555278 (UMLS CUI [1])
Eye Abnormalities
Item
any significant ophthalmologic abnormality
boolean
C0015393 (UMLS CUI [1])
Coumarins
Item
use of coumarins
boolean
C0010207 (UMLS CUI [1])
pregnancy; lactating
Item
pregnant or breast-feeding women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
pulmonary fibrosis; Lymphangiosis carcinomatosa
Item
pre-existing parenchymal lung disease such as pulmonary fibrosis, lymphangiosis and carcinomatosis (if this is the only presence of the disease)
boolean
C0034069 (UMLS CUI [1])
C0948588 (UMLS CUI [2])
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial